Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer
Clinical trial NCT01843062 · TERMINATED
Trial details
- NCT number
- NCT01843062
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-27
- Primary completion
- 2018-05-18
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.